scholarly article | Q13442814 |
P50 | author | Moira K B Whyte | Q91291745 |
P2093 | author name string | Ian Sabroe | |
David J Buttle | |||
Simon B Brown | |||
Robert F Storey | |||
Steven K Dower | |||
Jon R Ward | |||
Heather M Judge | |||
Lynne Bingle | |||
P433 | issue | 4 | |
P304 | page(s) | 831-838 | |
P577 | publication date | 2005-10-01 | |
P1433 | published in | Thrombosis and Haemostasis | Q15724413 |
P1476 | title | Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor | |
P478 | volume | 94 |
Q61883672 | A central role for monocytes in Toll-like receptor-mediated activation of the vasculature |
Q33443707 | Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains |
Q34491825 | Aggregation and microparticle production through toll-like receptor 4 activation in platelets from recently menopausal women |
Q36881887 | Brief Exercise Increases Peripheral Blood NK Cell Counts without Immediate Functional Changes, but Impairs their Responses to ex vivo Stimulation |
Q91895067 | Canine platelets express functional Toll-like receptor-4: lipopolysaccharide-triggered platelet activation is dependent on adenosine diphosphate and thromboxane A2 in dogs |
Q42133469 | Differential modulation of cytokine, chemokine and Toll like receptor expression in chickens infected with classical and variant infectious bursal disease virus |
Q91657132 | Effect of ultrapure lipopolysaccharides derived from diverse bacterial species on the modulation of platelet activation |
Q38310270 | Emerging evidence for platelets as immune and inflammatory effector cells |
Q36510868 | Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. |
Q33419814 | Expression and functionality of Toll-like receptor 3 in the megakaryocytic lineage |
Q42366210 | Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4. |
Q33433781 | Hyaluronan Depolymerization by Megakaryocyte Hyaluronidase-2 Is Required for Thrombopoiesis |
Q88158903 | Hyaluronan in inflammatory bowel disease: Cross-linking inflammation and coagulation |
Q58577394 | Impact of Escherichia coli K12 and O18:K1 on human platelets: Differential effects on platelet activation, RNAs and proteins |
Q28078773 | Intercellular Interactions as Regulators of NETosis |
Q42248441 | Lipopolysaccharide is a direct agonist for platelet RNA splicing |
Q33384817 | Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway |
Q37281999 | Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop |
Q92543091 | Macrophage Depletion Mitigates Platelet Aggregate Formation in Splenic Marginal Zone and Alleviates LPS-Associated Thrombocytopenia in Rats |
Q41200749 | P-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation. |
Q91971794 | Platelet Inflammatory Response to Stress |
Q41300060 | Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals |
Q37678953 | Platelet-bacterial interactions. |
Q40553193 | Platelet-borne complement proteins and their role in platelet-bacteria interactions. |
Q35124418 | Platelets and infections - complex interactions with bacteria. |
Q37657202 | Platelets and innate immunity |
Q37809184 | Platelets as Central Mediators of Systemic Inflammatory Responses |
Q37081746 | Platelets as cellular effectors of inflammation in vascular diseases |
Q34590168 | Platelets as immune mediators: Their role in host defense responses and sepsis |
Q26739670 | Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases |
Q39001947 | Platelets in neutrophil recruitment to sites of inflammation |
Q35101184 | Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum |
Q35037420 | Regulatory effects of TLR2 on megakaryocytic cell function |
Q37869814 | Review of cellular and molecular pathways linking thrombosis and innate immune system during sepsis. |
Q59791517 | Role of Platelets in Leukocyte Recruitment and Resolution of Inflammation |
Q33417641 | Role of platelet TLR4 expression in pathogensis of septic thrombocytopenia. |
Q42137745 | Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase |
Q27004467 | The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors |
Q93092336 | The Role of Human Platelet Preparation for Toll-Like Receptors 2 and 4 Related Platelet Responsiveness |
Q33413094 | The role of calpain-myosin 9-Rab7b pathway in mediating the expression of Toll-like receptor 4 in platelets: a novel mechanism involved in α-granules trafficking |
Q37640684 | The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes |
Q34765561 | The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. |
Q37869349 | The thrombotic potential of oral pathogens |
Q47147432 | Toll-Like Receptor 4 Signalling and Its Impact on Platelet Function, Thrombosis, and Haemostasis. |
Q36038084 | Toll-Like Receptor Signalling Is Not Involved in Platelet Response to Streptococcus pneumoniae In Vitro or In Vivo |
Q50115928 | Translational Implications of Platelets as Vascular First Responders |
Q37421811 | Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease |
Search more.